Patent · US Active

Kinase inhibitors

US7309787B2 · kind B2 · utility

0Cited by
13References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 6, 2006
Grant dateDec 18, 2007
Priority date
Expiry dateJul 6, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.